Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glononium bromide + formoterol versus tiotropium in Group B stable COPD with CAT < 20
ChiCTR2500110763Phase 4Completed
- Sponsor
- Zitong County People's Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of glycopyrronium bromide + formoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Zitong County People's Hospital. Primary endpoint: FEV1. Started Oct 2025; status: completed.
02
Drugs
glycopyrronium bromide + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2500110763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110763.